We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$188M
AUM Growth
+$30.7M
Cap. Flow
+$18.4M
Cap. Flow %
9.8%
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73

Top Buys

Rank Stock Value
1
TCPC icon
BlackRock TCP Capital
TCPC
+$1.06M
2
HST icon
Host Hotels & Resorts
HST
+$965K
3
PLTR icon
Palantir
PLTR
+$932K
4
PSA icon
Public Storage
PSA
+$920K
5
DFS
Discover Financial Services
DFS
+$865K

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$962K
2
PLD icon
Prologis
PLD
+$773K
3
BKNG icon
Booking.com
BKNG
+$734K
4
ETN icon
Eaton
ETN
+$720K
5
TEL icon
TE Connectivity
TEL
+$708K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Financials 20.16%
3 Technology 16.46%
4 Industrials 8.76%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HRMY icon
201
Harmony Biosciences
HRMY
$2.06B
$379K 0.2%
11,280
+1,623
+17% +$52.1K
DCPH
202
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$379K 0.2%
24,069
+3,463
+17% +$53.3K
OXSQ icon
203
Oxford Square Capital
OXSQ
$147M
$373K 0.2%
117,596
+27,120
+30% +$82.9K
IQI icon
204
Invesco Quality Municipal Securities
IQI
$530M
$372K 0.2%
38,472
+6,604
+21% +$63.1K
BCIC
205
BCP Investment Corp
BCIC
$87.9M
$372K 0.2%
19,589
+4,014
+26% +$75K
VKTX icon
206
Viking Therapeutics
VKTX
$3.89B
$370K 0.2%
4,511
-306
-6% -$13.6K
ROIV icon
207
Roivant Sciences
ROIV
$24.3B
$361K 0.19%
34,233
+4,925
+17% +$53.1K
FOLD
208
DELISTED
Amicus Therapeutics
FOLD
$361K 0.19%
30,604
+4,403
+17% +$56.3K
INSM icon
209
Insmed
INSM
$22.6B
$358K 0.19%
13,193
+1,898
+17% +$53.1K
MRCC
210
DELISTED
Monroe Capital Corp
MRCC
$358K 0.19%
49,660
+12,700
+34% +$92.1K
LEGN icon
211
Legend Biotech
LEGN
$3.69B
$348K 0.19%
6,207
+893
+17% +$53.9K
UTHR icon
212
United Therapeutics
UTHR
$26.1B
$345K 0.18%
1,500
+216
+17% +$48.7K
GILD icon
213
Gilead Sciences
GILD
$167B
$341K 0.18%
4,659
+670
+17% +$51.5K
BMRN icon
214
BioMarin Pharmaceuticals
BMRN
$11.9B
$341K 0.18%
3,904
+562
+17% +$50.3K
TVTX icon
215
Travere Therapeutics
TVTX
$5.19B
$340K 0.18%
44,150
+6,352
+17% +$53.6K
INCY icon
216
Incyte
INCY
$26.1B
$340K 0.18%
5,969
+859
+17% +$51.6K
BNTX icon
217
BioNTech
BNTX
$23.2B
$338K 0.18%
3,665
+527
+17% +$50.5K
SAGE
218
DELISTED
Sage Therapeutics
SAGE
$337K 0.18%
17,965
+2,585
+17% +$59.6K
IONS icon
219
Ionis Pharmaceuticals
IONS
$9.03B
$332K 0.18%
7,648
+1,100
+17% +$52.4K
BBIO icon
220
BridgeBio Pharma
BBIO
$16.5B
$328K 0.17%
10,611
+1,527
+17% +$51.9K
BIIB icon
221
Biogen
BIIB
$30.3B
$320K 0.17%
1,486
+214
+17% +$50.1K
ONC
222
BeOne Medicines Ltd
ONC
$34B
$318K 0.17%
2,031
+292
+17% +$47K
OFS icon
223
OFS Capital
OFS
$45.8M
$315K 0.17%
31,724
+6,377
+25% +$70.7K
TBPH icon
224
Theravance Biopharma
TBPH
$875M
$310K 0.16%
34,607
+4,979
+17% +$46.1K
ALNY icon
225
Alnylam Pharmaceuticals
ALNY
$38.2B
$305K 0.16%
2,043
+294
+17% +$49K
7 8
9
10 11

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus ETF Advisers held 495 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $18.4M of net new capital in Q1 2024, opening 69 new positions and adding to 189 existing holdings. Its largest new stake was Host Hotels & Resorts: 47,997 shares worth $993K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $569K trimmed.

  • Virtus ETF Advisers's largest Q1 2024 buy was Host Hotels & Resorts: 47,997 shares worth $993K.
  • Virtus ETF Advisers added most to BlackRock TCP Capital in Q1 2024, an estimated $1.06M increase.
  • Virtus ETF Advisers's biggest Q1 2024 reduction was ConocoPhillips, cutting an estimated $569K.
  • Virtus ETF Advisers fully exited Burlington in Q1 2024, selling an estimated $962K.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $188M portfolio in Q1 2024.
  • Virtus ETF Advisers opened 69 new positions and closed 73 in Q1 2024.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $188M.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.